Skip to content

A multicentre study to evaluate superficial fungal infections

A multicentric study to evaluate the hst and pathogen factors in recurrent dermatophytoses

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/07/009032
Enrollment
300
Registered
2017-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cases are patients with superficial dermatophytosis and controls are healthy volunteers

Interventions

None listed

Sponsors

Indian Association of Dermatologists Venereologists and Leprologists
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Study population 1.All patients above the age of 12 years diagnosed clinically to have recurrent dermatophytoses (excluding nail and scalp infections). Control Group: 1.First episode or Only single episode of tinea corporis/cruris/facei in last 12 months The inclusion criteria for centres: 1.There should be an NABL-accredited mycology laboratory equipped for standardized dermatophyte cuture available (the proof of such accreditation must be attached with the application). 2. The lab director or the mycologist in-charge must give signed consent in a pre-approved format: 1) agreeing to be a co-investigator for the project, and 2) agreeing to give unimpeded access to the lab for the said purpose (dermatophyte culture) during the full tenure of the project. 3. The Investigator must take full responsibility of and provide proof thereof facilities of transportation of biological samples from the site to PGIMER.

Exclusion criteria

Exclusion criteria: 1.Immunocompromised. 2.Pregnancy 3.Lactation

Design outcomes

Primary

MeasureTime frame
1. To estimate the prevalence and clinical patterns of recurrent dermatophytoses (excluding nail and scalp infections). Timepoint: 1 year

Secondary

MeasureTime frame
1. To evaluate the host and environmental risk factors associated with recurrent dermatophytoses. 2. To study the antifungal susceptibility patterns in these patients. 3. To study relationship between the potency and quantity of corticosteroid use with severity and chronicity of dermatophytosis Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Sunil Dogra

Post Graduate Institute of Medical Education and Research,Chandigarh

sundogra@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026